Position in PGEN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,347,753
+$583,788 QoQ
Shares Held
236,448
+19.8% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. PGEN ranks #118 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in PGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,347,753 | 236,448 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $763,965 | 197,407 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $824,605 | 197,274 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $709,880 | 215,769 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $281,270 | 198,078 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $284,645 | 191,037 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $220,790 | 197,134 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $174,606 | 183,796 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $320,251 | 202,691 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $294,548 | 203,137 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $278,720 | 208,000 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $296,856 | 209,054 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $230,826 | 200,719 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $185,905 | 175,383 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $233,620 | 153,698 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $311,726 | 147,041 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $178,952 | 133,547 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $207,929 | 98,545 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $371,096 | 100,026 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $509,454 | 102,095 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $641,294 | 98,358 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $618,453 | 89,761 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $983,647 | 96,436 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $312,203 | 89,201 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $508,336 | 101,871 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $380,531 | 111,921 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||